GED Capital makes a gross return of 4.0x invested capital and 38% IRR on Vitro Group's exit from GED Fund V

by Buenavista Equity Partners

GED Capital divested Vitro Group through a dual exit route, first selling its flow cytometry division (“Cytognos”) to the healthcare multinational Becton Dickinson in January 2022 and then its mol...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

CS Corporate Advisors advises on Condis...

by CS Corporate Advisors

The deal integrates into Condis’ structure eight supermarkets locate...

Photos Stream